📰 Von Hoff News
Page 2 - Von Hoff News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Von Hoff. Real-time updates on events, politics, business and more.
March 26, 2022
The new study has suggested that a ketogenic diet, which is low in carbohydrates and protein and high in fat, helps to kill pancreatic cancer cells when combined with a triple-drug therapy.
March 22, 2022
The findings of a new study suggest that a ketogenic diet -; which is low in carbohydrates and protein, but high in fat -; helps to kill pancreatic cancer cells when combined with a triple-drug therapy developed by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
March 22, 2022
The new study has suggested that a ketogenic diet, which is low in carbohydrates and protein and high in fat, helps to kill pancreatic cancer cells when combine
March 22, 2022
A new study suggests that a ketogenic diet, low in carbohydrates and protein but high in fat, can help kill pancreatic cancer cells when combined with a triple-drug therapy.
December 14, 2021
/PRNewswire/ -- The Foundation is excited to hold its first live, in-person weekend event since the pandemic hit. Expect a fun-filled weekend gathering of...
December 14, 2021
/PRNewswire/ -- The Foundation is excited to hold its first live, in-person weekend event since the pandemic hit. Expect a fun-filled weekend gathering of...
February 8, 2021
Press release content from Business Wire. The AP news staff was not involved in its creation. NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board February 8, 2021 GMT Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today the appointment of four leading pancreatic cancer experts to its Scientific Advisory Board (SAB). Led by the ne...
December 15, 2020
Compound derived from thunder god vine could improve outcomes for pancreatic cancer patients The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine -- an herb used in China for centuries to treat joint pain, swelling and fever -- is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer. The medicinal pla...
December 14, 2020
E-Mail PHOENIX, Ariz. -- Dec. 14, 2020 -- The results of a pre-clinical study led by researchers at the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, suggest how a compound derived from the thunder god vine -- an herb used in China for centuries to treat joint pain, swelling and fever -- is able to kill cancer cells and potentially improve clinical outcomes for patients with pancreatic cancer. The medicinal plants key ingredient, triptolide, is the basis of ...